Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Pain

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpain.2008.12.003PMID 19231296PMCID PMC2741410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy‐induced neuropathy

  2008cited by this paper
• Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.

  2008cited by this paper
• Epicatechin protects auditory cells against cisplatin-induced death

  2008cited by this paper
• Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.

  2008cited by this paper
• Cisplatin-mediated impairment of mitochondrial DNA metabolism inversely correlates with glutathione levels.

  2008cited by this paper
• Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.

  2007cited by this paper
• Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system.

  2007cited by this paper
• Antidepressants for neuropathic pain.

  2007cited by this paper
• Chemotherapy-induced neuropathy

  2007cited by this paper
• Neurologic complications of chemotherapy agents

  2007cited by this paper
• The resurgence of platinum-based cancer chemotherapy

  2007cited by this paper
• The pathophysiology of oxaliplatin-induced neurotoxicity.

  2006cited by this paper
• Difficult Pain Syndromes: Bone Pain, Visceral Pain, and Neuropathic Pain

  2006cited by this paper
• Studies of peripheral sensory nerves in paclitaxel‐induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction

  2006cited by this paper
• Management of chemotherapy-induced peripheral neuropathy

  2006cited by this paper
• Neurologic complications of cancer chemotherapy.

  2006cited by this paper
• Discordance of clinical symptoms and electrophysiologic findings in taxane plus platinum-induced neuropathy

  2006cited by this paper
• Update on pharmacotherapy guidelines for treatment of neuropathic pain

  2006cited by this paper
• Oxaliplatin and Axonal Na+ Channel Function In vivo

  2006cited by this paper
• Neuropathic pain: are we out of the woods yet?

  2006cited by this paper
• Mitochondrial electron transport in models of neuropathic and inflammatory pain

  2006cited by this paper
• Acetyl‐l‐carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study

  2006cited by this paper
• Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.

  2005cited by this paper
• Oxaliplatin-Associated Neuropathy: A Review

  2005cited by this paper
• Oxaliplatin‐induced neurotoxicity and the development of neuropathy

  2005cited by this paper
• Analysis of cytotoxicities of platinum compounds

  2005cited by this paper
• Treatment-related neurotoxicity.

  2005cited by this paper
• Oxaliplatin‐induced neurotoxicity: Acute hyperexcitability and chronic neuropathy

  2004cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• Caspase signalling in neuropathic and inflammatory pain in the rat

  2004cited by this paper
• Novel mechanism of enhanced nociception in a model of AIDS therapy‐induced painful peripheral neuropathy in the rat

  2004cited by this paper
• Oxaliplatin-safety profile: neurotoxicity.

  2003cited by this paper
• Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures.

  2002cited by this paper
• Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat.

  2002cited by this paper
• Nociceptor Sensitization by Extracellular Signal-Regulated Kinases

  2001cited by this paper
• Nucleolar damage correlates with neurotoxicity induced by different platinum drugs

  2001cited by this paper
• Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.

  2000cited by this paper
• Safety of oxaliplatin in the treatment of colorectal cancer.

  2000cited by this paper
• The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons.

  2000cited by this paper
• Role of Protein Kinase A in the Maintenance of Inflammatory Pain

  1999cited by this paper
• Pharmacokinetics and safety profile of oxaliplatin.

  1998cited by this paper
• High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria

  1997cited by this paper
• Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans.

  1996cited by this paper
• Involvement of the sympathetic postganglionic neuron in capsaicin-induced secondary hyperalgesia in the rat.

  1995cited by this paper
• Alkylating agents and platinum: is clinical resistance simply a tumor cell phenomenon?

  1991cited by this paper
• Alkylating and platinum-based agents.

  1990cited by this paper
• [Peripheral neuropathy caused by cisplatin in patients with lung cancer].

  1989cited by this paper
• A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

  1987cited by this paper
• Noble metal complexes in cancer chemotherapy.

  1977cited by this paper
• Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria.

  1977cited by this paper

• Tumor-Macrophage-Nerve interactions drive neuroinflammation and neuropathic pain in prostate cancer perineural invasion.

  2026cites this paper
• TET1 participates in oxaliplatin-induced neuropathic pain by regulating microRNA-30b/Nav1.6

  2025cites this paper
• Trichosanthes kirilowii Maxim. and Bioactive Compound Cucurbitacin D Alleviate Cisplatin-Induced Peripheral Neuropathy In Vitro and In Vivo

  2025cites this paper
• Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs

  2025cites this paper
• Animal models of cisplatin‐induced neuropathic pain

  2025cites this paper
• Design and synthesis of novel diclofenac-based quinazoline derivatives enhancing cisplatin and radiation impacts via MyD88 and COX-2/PGE2 modulation.

  2025cites this paper
• Neuroprotective Effects of Trimetazidine against Cisplatin-Induced Peripheral Neuropathy: Involvement of AMPK-Mediated PI3K/mTOR, Nrf2, and NF-κB Signaling Axes

  2024cites this paper
• G-protein-coupled estrogen receptor 30 regulation of signaling downstream of protein kinase Cε mediates sex dimorphism in hyaluronan-induced antihyperalgesia.

  2024cites this paper
• Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy‐induced painful peripheral neuropathy

  2024cites this paper
• Protective effects of Boswellia and Curcuma extract on oxaliplatin-induced neuropathy via modulation of NF-κB signaling

  2024cites this paper
• Cisplatin induced alterations in nociceptor developmental trajectory elicits a TrkA dependent platinum-based chemotherapy induced neuropathic pain.

  2024cites this paper
• Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies—In Vitro and In Vivo Characterization

  2024cites this paper
• Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy

  2024cites this paper
• Exploration for Blood Biomarkers of Human Long Non-coding RNAs Predicting Oxaliplatin-Induced Chronic Neuropathy Through iPS Cell-Derived Sensory Neuron Analysis

  2024cites this paper
• MMG22 potently blocks hyperalgesia in cisplatin-treated mice.

  2023cites this paper
• Chemotherapy for pain: reversing inflammatory and neuropathic pain with the anticancer agent mithramycin A

  2023cites this paper
• Efficacy of the Multi-Target Compound E153 in Relieving Pain and Pruritus of Different Origins

  2023cites this paper
• Red Ginger Extract Prevents the Development of Oxaliplatin-Induced Neuropathic Pain by Inhibiting the Spinal Noradrenergic System in Mice

  2023cites this paper
• Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain

  2023cites this paper
• Scyphocephalione A isolated from the stem bark of Scyphocephalium ochocoa (Myristicaceae) attenuate acute and chronic pain through the antiinflammatory activity

  2022cites this paper
• Gender and Sex-Related Differences in Normal Tissue Effects Induced by Platinum Compounds

  2022cites this paper
• Mitochondrial Reactive Oxygen Species Elicit Acute and Chronic Itch via Transient Receptor Potential Canonical 3 Activation in Mice

  2022cites this paper
• Effects of Oxaliplatin on Facial Sensitivity to Cool Temperatures and TRPM8 Expressing Trigeminal Ganglion Neurons in Mice

  2022cites this paper
• Cisplatin induces TRPA1-mediated mechanical allodynia in the oral mucosa.

  2021cites this paper
• Subcutaneous ω-Conotoxins Alleviate Mechanical Pain in Rodent Models of Acute Peripheral Neuropathy

  2021cites this paper
• Silymarin reduced cisplatin-induced hyperalgesia bysuppressing oxidative stress in male rats

  2021cites this paper
• Endothelin receptor type A is involved in the development of oxaliplatin-induced mechanical allodynia and cold allodynia acting through spinal and peripheral mechanisms in rats

  2021cites this paper
• Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability

  2021cites this paper
• Computational and Pharmacological Investigation of (E)-2-(4-Methoxybenzylidene)Cyclopentanone for Therapeutic Potential in Neurological Disorders

  2020cites this paper
• Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.

  2020cites this paper
• Computational and Pharmacological Investigation of (E)-2-(4-Methoxybenzylidene)Cyclopentanone for Therapeutic Potential in Neurological Disorders

  2020cites this paper
• Corydalis saxicola Alkaloids Attenuate Cisplatin-Induced Neuropathic Pain by Reducing Loss of IENF and Blocking TRPV1 Activation.

  2020cites this paper
• Falls and Cancer.

  2020cites this paper
• Computational and Pharmacological Investigation of (E)-2-(4-Methoxybenzylidene)Cyclopentanone for Therapeutic Potential in Neurological Disorders

  2020cites this paper
• Possible roles of mitochondrial dysfunction in neuropathy

  2020cites this paper
• Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons

  2020influential citation
• Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy.

  2020cites this paper
• Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies.

  2019cites this paper
• Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy

  2019cites this paper
• Identification and characterization of protein complexes involved in different pain states in vertebrates

  2019cites this paper
• Chronic pain and childhood cancer survivorship

  2019cites this paper
• The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain

  2019cites this paper
• The bivalent ligand MCC22 potently attenuates hyperalgesia in a mouse model of cisplatin-evoked neuropathic pain without tolerance or reward.

  2019cites this paper
• Pioglitazone, a PPAR&ggr; agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress

  2018cites this paper
• Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15

  2018cites this paper
• An updated understanding of the mechanisms involved in chemotherapy-induced neuropathy.

  2018cites this paper
• Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy‐induced neuropathy

  2018cites this paper
• NO-cGMP-K channel-dependent anti-nociceptive activities of methanol stem bark extract of Piptadeniastrum africanum (Mimosaceae) on rats

  2018cites this paper
• Distinct Mechanism of Cysteine Oxidation-Dependent Activation and Cold Sensitization of Human Transient Receptor Potential Ankyrin 1 Channel by High and Low Oxaliplatin

  2017influential citation
• Cancer Chemotherapy in Early Life Significantly Alters the Maturation of Pain Processing

  2017influential citation
• Cisplatin alters the function and expression of N-type voltage-gated calcium channels in the absence of morphological damage of sensory neurons

  2017cites this paper
• Chemotherapy-Induced Gastrointestinal Dysfunction and Enteric Neuropathy

  2017influential citation
• Duloxetine Protects against Oxaliplatin-Induced Neuropathic Pain and Spinal Neuron Hyperexcitability in Rodents

  2017cites this paper
• The effect of intraperitoneal chemotherapy on early pain hyperalgesia in patients following elective laparoscopic transabdominal resection of rectal cancer

  2017cites this paper
• Detection of Nausea-Like Response in Rats by Monitoring Facial Expression

  2017cites this paper
• The efficacy of combination treatment of gabapentin and electro-acupuncture on paclitaxel-induced neuropathic pain

  2017influential citation
• Ibudilast reduces oxaliplatin‐induced tactile allodynia and cognitive impairments in rats

  2017cites this paper
• Cisplatin‐induced neuropathic pain is mediated by upregulation of N‐type voltage‐gated calcium channels in dorsal root ganglion neurons

  2017cites this paper
• The role of DNA damage and repair in toxicity to postmitotic cells caused by cancer therapies

  2016cites this paper
• Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics

  2016cites this paper
• Combined Effects of Bee Venom Acupuncture and Morphine on Oxaliplatin-Induced Neuropathic Pain in Mice

  2016cites this paper
• New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy

  2016cites this paper
• Preventive Effects of Bee Venom Derived Phospholipase A2 on Oxaliplatin-Induced Neuropathic Pain in Mice

  2016cites this paper
• Standardized Profiling of The Membrane-Enriched Proteome of Mouse Dorsal Root Ganglia (DRG) Provides Novel Insights Into Chronic Pain*

  2016influential citation
• Cerebrospinal Fluid Oxaliplatin Contributes to the Acute Pain Induced by Systemic Administration of Oxaliplatin

  2016cites this paper
• Chemotherapy‐mediated pain and peripheral neuropathy: impact of oxidative stress and inflammation

  2016cites this paper
• Symptoms and pathology in neuropathic pain

  2016cites this paper
• Gr upSM Mitochondrial Dysfunction : A Key Player in the Pathogenesis of Neurodegeneration Associated Neuropathic Pain Syndrome

  2015influential citation
• Chemotherapy-induced peripheral neuropathy.

  2015cites this paper
• Mechanisms involved in the development of chemotherapy-induced neuropathy.

  2015cites this paper
• Peripheral neuropathic pain: signs, symptoms, mechanisms, and causes: are they linked?

  2015cites this paper
• Contribution of Piezo2 to endothelium-dependent pain

  2015cites this paper
• A hydro-ethanolic extract of Synedrella nodiflora (L.) Gaertn ameliorates hyperalgesia and allodynia in vincristine-induced neuropathic pain in rats

  2015cites this paper
• Contribution of Piezo2 to endothelium-dependent pain

  2015cites this paper
• Intravenous glutamine appears to reduce the severity of symptomatic platinum-induced neuropathy: a prospective randomized study

  2015cites this paper
• Cisplatin induced sensory neuropathy is prevented by vascular endothelial growth factor-A.

  2015cites this paper
• Analgesic Effects of Bee Venom Derived Phospholipase A2 in a Mouse Model of Oxaliplatin-Induced Neuropathic Pain

  2015cites this paper
• The effect of thioctic acid on allodynia in a rat vincristine-induced neuropathy model

  2015cites this paper
• A Visualized Guideline for Cancer Chemotherapy Induced Neuropathic Pain in Mice Using Cisplatin

  2015cites this paper
• Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)

  2015cites this paper
• Antihyperalgesic effect of tetrodotoxin in rat models of persistent muscle pain.

  2015cites this paper
• Calcium-related neurotoxicity of oxaliplatin: understanding the mechanisms to drive therapy.

  2015cites this paper
• Chemotherapy‐induced peripheral neurotoxicity (CIPN): what we need and what we know

  2014cites this paper
• Characterization of Acute and Chronic Neuropathies Induced by Oxaliplatin in Mice and Differential Effects of a Novel Mitochondria-targeted Antioxidant on the Neuropathies

  2014cites this paper
• The TRPA1 channel in inflammatory and neuropathic pain and migraine.

  2014cites this paper
• Calcium-permeable ion channels in pain signaling.

  2014cites this paper
• Altered discharges of spinal neurons parallel the behavioral phenotype shown by rats with bortezomib related chemotherapy induced peripheral neuropathy.

  2014cites this paper
• Differential pharmacological alleviation of oxaliplatin-induced hyperalgesia/allodynia at cephalic versus extra-cephalic level in rodents.

  2014cites this paper
• Mechanisms of Astrocyte Contribution to Bortezomib-Induced Peripheral Neuropathy

  2014cites this paper
• Advances in the Management of Oxaliplatin-Induced Neuropathy: Focus on Glutamine and Using Pharmacogenomics to Predict the Effectiveness of Opioid Drugs

  2014cites this paper
• Significant changes in mitochondrial distribution in different pain models of mice.

  2013cites this paper
• Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.

  2013cites this paper
• P2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo Approach

  2013cites this paper
• SALVIA OFFICINALIS AND CISPLATIN EFFECTS ON PENTYLENETETRAZOLE INDUCED SEIZURE THRESHOLD

  2013cites this paper
• Persistent Hyperalgesia in the Cisplatin-Treated Mouse as Defined by Threshold Measures, the Conditioned Place Preference Paradigm, and Changes in Dorsal Root Ganglia Activated Transcription Factor 3: The Effects of Gabapentin, Ketorolac, and Etanercept

  2013cites this paper
• The fundamental unit of pain is the cell.

  2013cites this paper
• Transient Receptor Potential Channels in Chemotherapy-Induced Neuropathy

  2013cites this paper
• Understanding the role of mitochondria in the pathogenesis of chronic pain

  2013cites this paper
• Significance of Kampo, Traditional Japanese Medicine, in Supportive Care of Cancer Patients

  2013cites this paper
• Pathobiology of Cancer Regimen-Related Toxicities

  2013cites this paper